Back to HRTX
D. E. Shaw & Co., Inc. HRTX Position History
Heron Therapeutics, Inc. • Healthcare
Quarters held
26
Latest value
$26K
Q3 2026
Peak value
$13.3M
First seen
Q2 2022
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q2 2022 | $4.5M |
| Q3 2022 | $3.2M |
| Q3 2022 | $635K |
| Q4 2022 | $1.8M |
| Q4 2022 | $189K |
| Q4 2023 | $136K |
| Q4 2023 | $2.1M |
| Q1 2024 | $7.5M |
| Q2 2024 | $188K |
| Q2 2024 | $13.3M |
| Q3 2024 | $8.5M |
| Q3 2024 | $267K |
| Q4 2024 | $247K |
| Q4 2024 | $5.5M |
| Q1 2025 | $6.2M |
| Q1 2025 | $369K |
| Q2 2025 | $655K |
| Q2 2025 | $6M |
| Q3 2025 | $491K |
| Q3 2025 | $3.4M |
| Q4 2025 | $403K |
| Q4 2025 | $3.5M |
| Q1 2026 | $226K |
| Q1 2026 | $1.9M |
| Q2 2026 | $51K |
| Q3 2026 | $26K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $26K | 81.7K | — | — |
| Q2 2026 | $51K | 120.4K | — | — |
| Q1 2026 | $1.9M | 2.32M | — | — |
| Q1 2026 | $226K | 282.2K | — | — |
| Q4 2025 | $3.5M | 2.69M | — | — |
| Q4 2025 | $403K | 309.9K | — | — |
| Q3 2025 | $3.4M | 2.70M | — | — |
| Q3 2025 | $491K | 389.7K | — | — |
| Q2 2025 | $6M | 2.88M | — | — |
| Q2 2025 | $655K | 316.2K | — | — |
| Q1 2025 | $369K | 167.6K | — | — |
| Q1 2025 | $6.2M | 2.82M | — | — |
| Q4 2024 | $5.5M | 3.56M | — | — |
| Q4 2024 | $247K | 161.4K | — | — |
| Q3 2024 | $267K | 134.4K | — | — |
| Q3 2024 | $8.5M | 4.25M | — | — |
| Q2 2024 | $13.3M | 3.81M | — | — |
| Q2 2024 | $188K | 53.7K | — | — |
| Q1 2024 | $7.5M | 2.70M | — | — |
| Q4 2023 | $2.1M | 1.21M | — | — |
| Q4 2023 | $136K | 80.0K | — | — |
| Q4 2022 | $189K | 75.7K | — | — |
| Q4 2022 | $1.8M | 711.4K | — | — |
| Q3 2022 | $635K | 150.4K | — | — |
| Q3 2022 | $3.2M | 749.2K | — | — |
| Q2 2022 | $4.5M | 1.61M | — | — |